Jean-Jacques Bienaim
2010
In 2010, Jean-Jacques Bienaim earned a total compensation of $5.4M as Chief Executive Officer at BioMarin Pharmaceutical, a 41% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $721,536 |
|---|---|
| Option Awards | $3,144,400 |
| Salary | $746,041 |
| Stock Awards | $774,360 |
| Other | $24,041 |
| Total | $5,410,378 |
Bienaim received $3.1M in option awards, accounting for 58% of the total pay in 2010.
Bienaim also received $721.5K in non-equity incentive plan, $746K in salary, $774.4K in stock awards and $24K in other compensation.
Rankings
In 2010, Jean-Jacques Bienaim's compensation ranked 920th out of 10,439 executives tracked by ExecPay. In other words, Bienaim earned more than 91.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 920 out of 10,439 | 91st |
Division Manufacturing | 324 out of 3,838 | 92nd |
Major group Chemicals And Allied Products | 74 out of 921 | 92nd |
Industry group Drugs | 43 out of 680 | 94th |
Industry Pharmaceutical Preparations | 36 out of 481 | 93rd |
Source: SEC filing on March 23, 2012.
Bienaim's colleagues
We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2010.
2010
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2010
Stephen Aselage
BioMarin Pharmaceutical
Executive Vice President & Chief Business Officer
2010
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2010
Jeffrey Cooper
BioMarin Pharmaceutical
Chief Financial Officer
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019